Have a personal or library account? Click to login
History of Botulinum Toxin Treatment in Movement Disorders Cover

History of Botulinum Toxin Treatment in Movement Disorders

Tremor and Other Hyperkinetic Movements
Volume 6 (2016): Issue 0
By: Bahman Jabbari  
Open Access
|Nov 2016

References

  1. 1
    DevriesePOn the discovery of Clostridium botulinumJ Hist Neurosci199984350doi: 10.1076/jhin.8.1.43.177411624135
    Back to article
  2. 2
    DrachmanDBPharmacological denervation of skeletal muscle in chick embryos treated with botulinum toxinTrans Am Neurol Assoc1965902412425323372
    Back to article
  3. 3
    PickettAPharmacological properties and factors that influence toxin actionToxicon200954683689doi: 10.1016/j.toxicon.2009.03.02019332087
    Back to article
  4. 4
    RossettoOMegighianAScorzetoMMontecuccoCBotulinum neurotoxinsToxicon2013673136doi: 10.1016/j.toxicon.2013.01.01723435262
    Back to article
  5. 5
    SöllnerTWhiteheartSWBrunnerMet alSNAP receptors implicated in vesicle targeting and fusionNature199336318324
    Back to article
  6. 6
    BlasiJChapmanERLinkEet alBotulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25Nature1993365160163doi: 10.1038/365160a08103915
    Back to article
  7. 7
    ErbguthFJNaumannMHistorical aspects of botulinum toxin: Justinus Kerner (1786–1862) and the “sausage poison”Neurology19995318501853doi: 10.1212/WNL.53.8.185010563638
    Back to article
  8. 8
    ErbguthFJNaumannMOn the first systematic descriptions of botulism and botulinum toxin by Justinus Kerner (1786-1862)J Hist Neurosci20009218220doi: 10.1076/0964-704X(200008)9:2;1-Y;FT21811232521
    Back to article
  9. 9
    ErbguthFJHistorical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxinMov Disord200419Suppl. 8S26doi: 10.1002/mds.2000315027048
    Back to article
  10. 10
    PeckhamELLopezGShamimEAet alClinical features of patients with blepharospasm: a report of 240 patientsEur J Neurol201118382386doi: 10.1111/j.1468-1331.2010.03161.x20649903
    Back to article
  11. 11
    JankovicJFahnSDystonic disordersJankovicJTolosaEeditorsParkinson’s disease and Movement Disorders1993337
    Back to article
  12. 12
    FruehBRFeltDPWojnoTHMuschDCTreatment of blepharospasm with botulinum toxin. A preliminary reportArch Ophthalmol198410214641468doi: 10.1001/archopht.1984.010400311840146385932
    Back to article
  13. 13
    ScottABKennedyRAStubbsHABotulinum A toxin injection as a treatment for blepharospasmArch Ophthalmol1985103347350doi: 10.1001/archopht.1985.010500300430173977705
    Back to article
  14. 14
    FahnSListTMoscowitzCet alDouble blind controlled study of botulinum toxin for blepharospasmNeurology198535Suppl. 1271
    Back to article
  15. 15
    JankovicJOrmanJBotulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled studyNeurology198737616623doi: 10.1212/WNL.37.4.6163561773
    Back to article
  16. 16
    GreenePFahnSBrinMFBlitzerABotulinum toxin therapyMarsdenCDFahnSMovement disorder 3. Chapter 24, CambridgeButterworth and HeinmanUK1994479
    Back to article
  17. 17
    KarpBIAlterKBotulinum toxin treatment of blepharospasm, orofacial/oromandibular dystonia, and hemifacial spasmSemin Neurol2016368491doi: 10.1055/s-0036-157195226866500
    Back to article
  18. 18
    PeckhamELLopezGShamimEAet alClinical features of patients with blepharospasm: a report of 240 patientsEur J Neurol201118382386doi: 10.1111/j.1468-1331.2010.03161.x20649903
    Back to article
  19. 19
    SimpsonDMHallettMAshmanEJet alPractice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development Subcommittee of the American Academy of NeurologyNeurology20168618181826doi: 10.1212/WNL.000000000000256027164716
    Back to article
  20. 20
    ChaudhryNSrivastavaAJoshiLHemifacial spasm: the past, present and futureJ Neurol Sci20153562731doi: 10.1016/j.jns.2015.06.03226111430
    Back to article
  21. 21
    AbabnehOHCetinkayaAKulwinDRLong-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasmClin Experiment Ophthalmol201442254261doi: 10.1111/ceo.1216523844601
    Back to article
  22. 22
    BatlaAGoyalCShuklaGGoyalVSrivastavaABehariMHemifacial spasm: clinical characteristics of 321 Indian patientsJ Neurol201225915611565doi: 10.1007/s00415-011-6376-322222858
    Back to article
  23. 23
    SavinoPJSergottRCBosleyTMSchatzNJHemifacial spasm treated with botulinum A toxin injectionArch Ophthalmol198510313051306doi: 10.1001/archopht.1985.010500900570314038122
    Back to article
  24. 24
    HallettMAlbaneseADresslerDet alEvidence-based review and assessment of botulinum neurotoxin for the treatment of movement disordersToxicon20136794114doi: 10.1016/j.toxicon.2012.12.00423380701
    Back to article
  25. 25
    FrenchJGronsethGLost in a jungle of evidence: we need a compassNeurology20087116341638doi: 10.1212/01.wnl.0000336533.19610.1b19001254
    Back to article
  26. 26
    GronsethGFrenchJPractice parameters and technology assessments: what they are, what they are not, and why you should careNeurology20087116391643doi: 10.1212/01.wnl.0000336535.27773.c019001255
    Back to article
  27. 27
    YoshimuraDMAminoffMJTamiTAScottABTreatment of hemifacial spasm with botulinum toxinMuscle Nerve19921510451049doi: 10.1002/mus.8801509091518513
    Back to article
  28. 28
    SampaioCFerreiraJJSimoesFet alDYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A–dysport and botox–assuming a ratio of 4:1Mov Disord19971210131018doi: 10.1002/mds.8701206279399229
    Back to article
  29. 29
    SteevesTDDayLDykemanJJetteNPringsheimTThe prevalence of primary dystonia: a systematic review and meta-analysisMov Disord20121417891796doi: 10.1002/mds.25244
    Back to article
  30. 30
    JankovicJAdlerCHCharlesDet alPrimary results from the cervical dystonia patient registry for observation of onabotulinumtoxinA efficacy (CD PROBE)J Neurol Sci20153498493doi: 10.1016/j.jns.2014.12.03025595221
    Back to article
  31. 31
    TsuiJKEisenAMakECarruthersJScottACalneDBA pilot study on the use of botulinum toxin in spasmodic torticollisCan J Neurol Sci198512314316doi: 10.1017/S031716710003540X4084867
    Back to article
  32. 32
    TsuiJKEisenAStoesslAJCalneSCalneDBDouble-blind study of botulinum toxin in spasmodic torticollisLancet19862245247doi: 10.1016/S0140-6736(86)92070-22874278
    Back to article
  33. 33
    GreenePKangUFahnSet alDouble-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollisNeurology19904012131218doi: 10.1212/WNL.40.8.12132199847
    Back to article
  34. 34
    LewMFAdornatoBTDuaneDDet alBotulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystoniaNeurology199749701707doi: 10.1212/WNL.49.3.7019305326
    Back to article
  35. 35
    BledsoeIOComellaCLBotulinum toxin treatment of cervical dystoniaSemin Neurol2016364753doi: 10.1055/s-0035-157121026866496
    Back to article
  36. 36
    FruchtSJFocal task-specific dystonia of the musicians’ hand—a practical approach for the clinicianJ Hand Ther200922136142doi: 10.1016/j.jht.2008.11.00619272752
    Back to article
  37. 37
    CohenLGHallettMGellerBDHochbergFTreatment of focal dystonias of the hand with botulinum toxin injectionsJ Neurol Neurosurg Psychiatry198952355363doi: 10.1136/jnnp.52.3.3552926421
    Back to article
  38. 38
    YoshimuraDMAminoffMJOlneyRKBotulinum toxin therapy for limb dystoniasNeurology199242627630doi: 10.1212/WNL.42.3.6271549227
    Back to article
  39. 39
    TsuiJKBhattMCalneSCalneDBBotulinum toxin in the treatment of writer’s cramp: a double-blind studyNeurology19934318385doi: 10.1212/WNL.43.1_Part_1.1838423882
    Back to article
  40. 40
    ColeRHallettMCohenLGDouble-blind trial of botulinum toxin for treatment of focal hand dystoniaMov. Disord199510466471doi: 10.1002/mds.8701004117565828
    Back to article
  41. 41
    KruisdijkJJKoelmanJHOngerboer de VisserBWde HaanRJSpeelmanJDBotulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-upJ Neurol Neurosurg Psychiatry200778264270doi: 10.1136/jnnp.2005.08317017185301
    Back to article
  42. 42
    HallettMBeneckeRBlitzerAComellaCLTreatment of focal dystonias with botulinum neurotoxinToxicon200954628633doi: 10.1016/j.toxicon.2008.12.00819103214
    Back to article
  43. 43
    LunguCKarpBIAlterKZolbrodRHallettMLong-term follow-up of botulinum toxin therapy for focal hand dystonia: outcome at 10 years or moreMov Disord201126750753doi: 10.1002/mds.2350421506157
    Back to article
  44. 44
    LudlowCLTreatment of speech and voice disorders with botulinum toxinJAMA199026720712076
    Back to article
  45. 45
    BlitzerABrinMFFahnSLovelace RE Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia)Laryngoscope198898193197doi: 10.1002/mds.8700204023339931
    Back to article
  46. 46
    BlitzerABrinMFStewartCFBotulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patientsLaryngoscope201512517511757doi: 10.1097/00005537-199810000-0000326200329
    Back to article
  47. 47
    LotiaMJankovicJBotulinum toxin for the treatment of tremor and ticsSemin Neurol2016365463doi: 10.1055/s-0035-157121726866497
    Back to article
  48. 48
    JankovicJSchwartzKBotulinum toxin treatment of tremorsNeurology19914111851188doi: 10.1212/WNL.41.8.11851866001
    Back to article
  49. 49
    JankovicJSchwartzKClemenceWAswadAMordauntJA randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremorMov Disord199611250256doi: 10.1002/mds.8701103068723140
    Back to article
  50. 50
    BrinMFLyonsKEDoucetteJet alA randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremorNeurology20015615231528doi: 10.1212/WNL.56.11.152311402109
    Back to article
  51. 51
    PullmanSLGreenePFahnSPedersenSFApproach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patientsArch Neurol199653617624doi: 10.1001/archneur.1996.005500700550128929169
    Back to article
  52. 52
    HendersonJMGhikaJAVan MelleGHallerEEinsteinRBotulinum toxin A in non-dystonic tremorsEur Neurol1996362935doi: 10.1159/0001171968719647
    Back to article
  53. 53
    ShivamOMMachadoDRichardsonBJabbariBIncoboyulinum toxin A (Xeomin) for treatment of Parkinson tremorA customized approachAAN.2016 Abstract #11896
    Back to article
  54. 54
    JankovicJKurlanRTourette syndrome: evolving conceptsMov disord20112611491115doi: 10.1002/mds.2361821484868
    Back to article
  55. 55
    BajwaRJde LotbinièreAJKingRAet alDeep brain stimulation in Tourette's syndromeMov Disord20072213461350doi: 10.1002/mds.2139817580320
    Back to article
  56. 56
    JankovicJBotulinum toxin in the treatment of dystonic ticsMov Disord19949347349doi: 10.1002/mds.8700903158041378
    Back to article
  57. 57
    KwakCHHannaPAJankovicJBotulinum toxin in the treatment of ticsArch Neurol20005711901193doi: 10.1001/archneur.57.8.119010927800
    Back to article
  58. 58
    PortaMMaggioniGOttavianiFet alTreatment of phonic tics in patients with Tourette's syndrome using botulinum toxin type ANeurol Sci200424420423doi: 10.1007/s10072-003-0201-414767691
    Back to article
  59. 59
    MarrasCAndrewsDSimeELangAEBotulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trialNeurology200156605610doi: 10.1212/WNL.56.5.60511245710
    Back to article
  60. 60
    TermsarasabPThammongkolchaiTFruchtSJSpinal-generated movement disorders: a clinical reviewJ Clin Mov Disord2015218doi: 10.1186/s40734-015-0028-126788354
    Back to article
  61. 61
    PoloKBJabbariBEffectiveness of botulinum toxin type A against painful limb myoclonus of spinal cord originMov Disord19949233235doi: 10.1002/mds.8700902218196691
    Back to article
  62. 62
    LaguenyATisonFBurbaudPLe MassonGKienPStimulus-sensitive spinal segmental myoclonus improved with injections of botulinum toxin type A. Stimulus-sensitive spinal segmental myoclonus improved with injections of botulinum toxin type AMov Disord1999182185doi: 10.1002/1531-8257(199901)14:1<182::AIDMDS1040>3.0.CO;2-89918374
    Back to article
  63. 63
    CamposCRLimongiJCMachadoFCBrottoMWA case of primary spinal myoclonus: clinical presentation and possible mechanisms involved. A case of primary spinal myoclonus: clinical presentation and possible mechanisms involvedArq Neuropsiquiatr200361112114doi: 10.1590/S0004-282X200300010002212715032
    Back to article
  64. 64
    van der SalmSMErroRCordivariCet alPropriospinal myoclonus: clinical reappraisal and review of literatureNeurology20148318621870doi: 10.1212/WNL.000000000000098225305154
    Back to article
  65. 65
    SpillaneJDNathanPWKellyREMarsdenCDPainful legs and moving toesBrain197194541556doi: 10.1002/mds.228694255783
    Back to article
  66. 66
    WaltersASHeningWAShahSKChokrovertySPainless legs and moving toes: a syndrome related to painful legs and moving toes?Mov Disord19938377379doi: 10.1002/mds.8700803258341307
    Back to article
  67. 67
    JabbariBMolloyFMEricksonMFloeterMKBilateral painful hand-moving fingers: electrophysiological assessment of the central nervous system oscillatorMov Disord20001512591263doi: 10.1002/1531-8257(200011)15:6<1259::AID-MDS1032>3.0.CO;2-5
    Back to article
  68. 68
    DresslerDThompsonPDGledhillRFMarsdenCDThe syndrome of painful legs and moving toesMov Disord199491321doi: 10.1002/mds.8700901047511213
    Back to article
  69. 69
    SupiotFGazagnesMDBlecicSAZegers de BeylDPainful arm and moving fingers: clinical features of four new casesMov Disord200217616618doi: 10.1002/mds.1011612112222
    Back to article
  70. 70
    SingerCPapapetropoulosSa case of painless arms/moving fingers responsive to botulinum toxin a injectionsParkinsonism Relat Disord2007135556doi: 10.1016/j.parkreldis.2006.03.00316723267
    Back to article
  71. 71
    EisaMSingerCSengunCRusselAJabbariBPapapetropoulosSTreatment of painful limbs/moving extremities with botulinum toxin type A injectionsEur Neurol200860104106doi: 10.1159/00013896218552499
    Back to article
  72. 72
    SchofferKPainful leg moving toes treated with botulinum toxin type A: a video reportMov Disord201025784785doi: 10.1002/mds.2286920310048
    Back to article
DOI: https://doi.org/10.5334/tohm.321 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Apr 8, 2016
Accepted on: Oct 25, 2016
Published on: Nov 28, 2016
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Movement disorders,
dystonia,
botulinumtoxin,
onabotulinumtoxinA,
abobotulinumtoxinA,
incobotulinumtoxinA,
rimabotulinum toxinB

© 2016 Bahman Jabbari, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.

Previous articleVolume 6 (2016): Issue 0Next article